1,146
Views
0
CrossRef citations to date
0
Altmetric
Article Commentary

Predictive Survival Power of Combined Tumor Regression Grade (TRG) and Lymph Node Status in Patients with Esophageal Cancer

Pages 1-2 | Received 06 Oct 2022, Accepted 27 Oct 2022, Published online: 09 Nov 2022

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313]. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–7943. doi:10.3748/wjg.v21.i26.7933.
  • van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084. doi:10.1056/NEJMoa1112088
  • Eyck BM, van Lanschot JJB, Hulshof MCCM, CROSS Study Group, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: The randomized controlled CROSS trial. J Clin Oncol. 2021;39(18):1995–2004. doi:10.1200/JCO.20.03614.
  • Yang H, Liu H, Chen Y, AME Thoracic Surgery Collaborative Group, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): A phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36(27):2796–2803. doi:10.1200/JCO.2018.79.1483.
  • Xie JW, Lu J, Xu BB, et al. Prognostic value of tumor regression grading in patients treated with neoadjuvant chemotherapy plus surgery for gastric cancer. Front Oncol. 2021;11:587856. doi:10.3389/fonc.2021.587856.
  • Lerttanatum N, Tharavej C, Chongpison Y, Sanpavat A. Comparison of tumor regression grading system in locally advanced esophageal squamous cell carcinoma after preoperative radio-chemotherapy to determine the most accurate system predicting prognosis. J Gastrointest Oncol. 2019;10(2):276–282. doi:10.21037/jgo.2018.12.01.
  • Gu YM, Lyu SM, Shang QX, et al. Is tumor regression grade sufficient to predict survival in esophageal cancer with trimodal therapy?. J Invest Surg. 2022;35(11–12):1818–1823. doi:10.1080/08941939.2022.2127036.